biOasis Technologies Ord Shs BIOAF

Primary Symbol: V.BTI.H

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs > beenthere Responds to My Post

<< Previous

Bullboard Posts

Next >>

Comment by Boomskidon Aug 23, 2023 11:34pm

61 Views

Post# 35603119

RE:RE:RE:RE:beenthere Responds to My Post

No, no. It's ok, TT.

I'll stick with my views on things.

And you can make your case for the Sappy Cap flap.

What you posted was gibberish, but I'm sure you have the whole story.

We'll wait for you.

We all admire your smarts and knowledge.

We're confident you can explain it.

If you don't mind, though, (snicker, snicker...) I might go with the facts.

Say. Was it the Sappy Cap stuff that drove the partners away?

I thought it was because xB3 was no good.

I'm sure you'll explain the whole thing.

jd

<< Previous

Bullboard Posts

Next >>

Rig Count Soars as Utilization Surpasses Industry Averages